Combination of terlipressin and noradrenaline versus terlipressin in hepatorenal syndrome with early non-response to terlipressin infusion: A randomized trial-Reference-Cited by-同舟云学术

Combination of terlipressin and noradrenaline versus terlipressin in hepatorenal syndrome with early non-response to terlipressin infusion: A randomized trial

Published:2023-05-05 Issue:3 Volume:42 Page:388-395
ISSN:0254-8860
Container-title:Indian Journal of Gastroenterology
language:en
Short-container-title:Indian J Gastroenterol

Author:

Singh Virendra^ORCID,Jayachandran Akshaya,De Arka,Singh Akash,Chandel Shivani,Sharma Navneet

Funder

Society for the Study of Liver Diseases

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s12664-023-01356-6.pdf

Reference18 articles.

1. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151–7.

2. Sanyal AJ, Boyer T, Garcia-Tsao G, et al. A randomized prospective double blind, placebo controlled study of terlipressin for type 1 hepatorenal syndrome. Gastroenterology. 2008;134:1360–8.

3. Martin-Llahi M, Pepin MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study. Gastroenterology. 2008;134:1352–9.

4. Rodriguez E, Elia C, Sola E, et al. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis. J Hepatol. 2014;60:955–61.

5. Cavallin M, Kamath PS, Merli M, et al. Terlipressin plus albumin vs. midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial. Hepatology. 2015;62:567–74.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-09-04

2. A Review of Terlipressin in Hepatorenal Syndrome: Targeting Endothelial Dysfunction and Subsequent Cardiovascular Adverse Events;Cardiology in Review;2024-06-04

3. Management of hepatorenal syndrome and associated outcomes: a systematic review;BMJ Open Gastroenterology;2024-04

4. Predictors of Short-term Mortality in Patients of Cirrhosis of Liver Presenting as Acute Kidney Injury: An In-hospital Prospective Observational Study;Journal of Clinical and Experimental Hepatology;2023-11

5. Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI);Expert Review of Gastroenterology & Hepatology;2023-10-27